Begrænsning af humane medicinrester og antibiotikaresistens i spildevand med fokus på reduktion ved kilden

8 Referencer

Ayscough, N. J., J. Fawell, G. Franklin and W. Young (2002), Review of Human Pharmaceuticals in the Environment, R&D Technical Report P390, ISBN: 1 85705 411 3, Environmental Agency, UK.

Balcioglu, Isil Akmehmet and Merih Ötker (2003), Treatment of pharmaceutical wastewater containing antibiotics by O3 and O3/H2O2 processes, ELSEVIER, Chemosphere, Vol. 50, pp 85-95.

Beausse, Johanne (2004), Selected drugs in solid matrices: A review of environmental occurrence, determination and properties of principal substances, Horizontal-26 Pharmaceuticals, July 2004.

Buffle, Marc-Olivier, Jochen Schumacher, Elisabeth Salhi, Martin Jekel and Urs von Gunten (2006), Measurement of the initial phase of ozone decomposition in water and wastewater by means of a continuous quench-flow system: Application to disinfection and pharmaceutical oxidation, ELSEVIER, Water Research, Vol. 40, pp 1884-1894.

Carballa, M., F. Omil and J.M. Lema (2005), Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment, ELSEVIER, Water Research, Vol. 39, pp 4790-4796.

Carballa, M., F. Omil, J.M. Lema, M. Llompart, C. Carcía-Jares, I. Rodríguez, M. Gómez and T. Ternes (2004), Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, ELSEVIER, Water Research, Vol. 38, pp 2918-2926.

Christensen, A.M. (in press) Drugs in Danish and Swedish hospital waste water - Concentrations and effects.

Clara M., B. Strenn, O. Gans, E. Martinez, N. Kreuzinger and H. Kroiss (2005), Removal of selected pharmaceuticals, fragrances and endocrine disruptiong compounds in membrane bioreactor and conventional wastewater treatment plants, ELSEVIER, Water Research, Vol. 39, pp 4797-4807.

Clara, M., B. Strenn, M. Ausserleitner and N. Kreuzinger (2004), Comparison of the behaviour of selected micro pollutants in a membrane bioreactor and a conventional wastewater treatment plant, Water Science and Technology, Vol. 50, No. 5, pp 29-36.

EU (2006), Guideline on the environmental risk assessment of medicinal products for human use, http://www.emea.eu.int/pdfs/human/swp/444700en.pdf, Date for coming into effect: 01 December 2006.

Golet, Eva M., Irene Xifra, Hansruedi Siegrist, Alfredo C. Alder and Walter Giger (2003), Environmental Exposure Assessment of Fluoroquinolone Antibacterial Agents from Sewage to Soil, Environmental Science & Technology Vol. 37, No 15, pp 3243-3249.

Göbel, A., C.S. McArdell, A. Joss and W. Giger, Occurrence and Sorption Behavior of Sulfonamides, Macrolides and Trimetthoprim in Activated Sludge Treatment (2005), Environmental Science & Technology, Vol. 39, pp 3961-3989.

Halling-Sørensen, B., Nielsen, S.N., Lanzky, P.F., Ingerslev, F., Lützhøft H.C. and S.E. Jørgensen (1998), Occurence, Fate and Effects of Pharmaceutical Substances in the Environment - A Review, ELSEVIER, Chemosphere, Vol. 36, No. 2, pp 357-393.

Halling-Sørensen, B. (2001), Inhibition of Aerobic Growth and Nitrification of Bacteria in Sewage Sludge by Antibacterial Agents, Archives of Environmental Contamination and Toxicology, Vol. 40, No. 4, pp 451-460.

Hijnen, W.A.M., E.F. Beerendonk and G.J. Medema (2006), Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: A review, ELSEVIER, Water Research, Vol. 40, pp 3-22.

Huber, Marc M., Silvio Canonica, Gun-Young Park and Urs von Gunten (2003), Oxidation of Pharmaceuticals during Ozonation and Advanced Oxidation Processes, Environmental Science & Technology, Vol. 37, No. 5, pp 1016-1024.

Huber, Marc M., Anke Göbel, Adriano Joss, Nadine Hermann, Dirk Löffler, Christa S. Mcardell, Achim Ried, Hansruedi Siegrist, Thomas A. Ternes and Urs von Gunten (2005), Oxidation of Pharmaceuticals during Ozonation of Municipal Wastewater Effluents: A Pilot Study, Environmental Science & Technology, Vol. 39, No. 11, pp 4290-4299.

Joss, Adriano, Elvira Keller, Alfredo C. Alder, Anke Göbel, Christa S. McArdell, Thomas Ternes and Hansruedi Siegrist (2005), Removal of pharmaceuticals and fragrances in biological wastewater treatment, ELSEVIER, Water Research, Vol. 39, pp 3139-3152.

Kimura, Katsuki; Shiho Toshima; Gary Amy and Yoshimasa Watanabe (2003), Rejection of neutral endocrine disrupting compounds (EDSs) and pharmaceutical active compounds (PhACs) by RO membranes, ELSEVIER, ELSEVIER, Journal of Membrane Science, Vol. 245, pp 71-78.

Kimura, Katsuki, Hiroe Hara and Yoshimasa Watanabe (2005), Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs), ELSEVIER, Desalination, Vol. 178, pp 135-140.

Kobberø, Claus (2003), Dykkede membraner – et oplagt alternative til traditional spildevandsrensning, Spildevandsteknisk Tidsskrift, nr. 2, pp 34-36.

Koivunen, J. and H. Heinonen-Tanski (2005), Inactivation of enteric microorganisms with chemical disinfectants, UV irradiation and combined chemical/UV treatments, ELSEVIER, Water Research, Vol. 39, pp 1519-1526.

Kümmerer, Klaus (2001), Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review, ELSEVIER, Chemosphere, Vol. 45, pp 957-969.

Kümmerer K. and A. Henninger (2003), Promoting resistance by the emission of antibiotics from hospitals and households into effluent, Clinical Microbiology & Infection, Vol. 9, pp 1203-1214.

Kümmerer, K. (2004), Pharmaceuticals in the Environment – Sources, Fate, Effects and Risks – 2nd Edition, Springer, ISBN 3540213422.

Larsen, Tove A., Judit Lienert, Adriano Joss and Hansruedi Siegrist (2004), How to avoid pharmaceuticals in the aquatic environment, ELSEVIER, Journal of Biotechnology, Vol. 113, pp 295-304.

Lawrence K. Wang, Yung-Tse Hung and Nazih K. Shammas (2005), Physicochemical Treatment Processes (Handbook of Environmental Engineering, Vol. 3), Publisher: Humana Press, 2Rev Ed edition (March 2005), ISBN: 1588291650.

Ljunggren, Michael (2006), Micro screening in wastewater treatment – an overview, Vatten 2, pp 171-177.

Lynettefællesskabet I/S (2004), Pilotskalatest af UV-behandling af spildevand fra Hvidovre Hospital med henblik på reduktion af antibiotikaresistente bakterier, Rapport udarbejdet af DHI - Institut for Vand og Miljø.

Lynettefællesskabet I/S (2005), Estimering af mængder og koncetrationer af antibiotika afledt fra sygehuse og den primære sundhedssektor i Lynettefællesskabets kloakoplande, Rapport udarbejdet af DHI - Institut for Vand og Miljø.

Läkemedelsverket (2004), Miljöpåverkan från läkemedel samt kosmetiska och hygieniska produkter, Rapport från Läkemedelsverket, Uppsala.

Madsen, I.B. (2005) Lægemidler i oplandet til Vejle Fjord - Kortlægning af forbruget af lægemidler og deres miljøbelastning i oplandet til Vejle Fjord, Vejle Amt.

Miljøstyrelsen (2002a), Environmental Assessment of Veterinary Medicinal Products in Denmark, Miljøprojekt, 659.

Miljøstyrelsen (2002b), Litteraturudredning vedrørende human medicin i miljøet, Miljøprojekt, 661.

Miljøstyrelsen (2002c), Occurrence and fate of antibiotic resistant bacteria in sewage, Miljøprojekt, 722.

Miljøstyrelsen (2003), Hormonforstyrrende stoffer og lægemidler i spildevand, Miljøprojekt, 799.

Miljøstyrelsen (2004), Degradation of Estrogens in Sewage Treatment Processes, Miljøprojekt, 899.

Miljøstyrelsen (2005), Survey of Estrogenic Activity in the Danish Aquatic Environment, Miljøprojekt, 977.

Miljøstyrelsen (2006), Tilslutning af industrispildevand til offentlige spildevandsanlæg, Vejledning fra Miljøstyrelsen, Nr. 2.

Møskeland T. (2006), Kartlegging av utvalgte forbindelser i legemidler og kosmetikk, Oppdragsgiver: Statens forurensningstilsyn (SFT), Utførende institusjon: Det Norske Veritas (DNV), SPFO-rapport: 949/2006, TA-2156/2006, ISBN 82-7655-283-8.

NERI (1998), Sources of Phthalates and Nonylphenoles in Municipal Waste Water. A Study in a Local Environment, Technical Report No. 225, Ministry of Environment and Energy, National Environmental Research Institute.

Neyens, E. and J. Baeyens (2003), A review of classic Fenton’s peroxidation as an advanced oxidation technique, ELSEVIER, Journal of Hazardous Materials B98, pp 33-50.

Nghiem, Long D., Andrea I. Schäfer and Menachem Elimelech (2005), Pharmaceutical Retention Mechanisms by Nanofiltration Membranes, Environmental Science & Technology, Vol. 39, No. 19, pp 7698-7705.

Patermarakis, G. & Fountoukidis, E. (1990), Disinfection of water by electrochemical treatment, ELSEVIER, Water Research, Vol. 24, No. 12, pp 1491-1496.

Pauwels, B., F. Fru Ngwa, S. Deconinck and W. Verstraete (2006), Effluent quality of a conventional activated sludge and a membrane bioreactor system treating hospital wastewater, Environmental Technology, Vol. 27, Issue 4, pp 395-402.

Pineau, Claire and Bernd Heinzmann (2005), Getrennte Erfassung von jodorganischen Röntgenkontrastmitteln in Krankenhäusern, Wasser - Abwasser GWF 146, Nr. 9, pp 646-653.

Poseidon: http:/www.eu-poseidon.com

Produktresumé (2006): http://www.produktresume.dk/docushare/dsweb/View/Collection-10)

Pronk, W., H. Palmquist, M. Biebow and M. Boller (2006), Nanofiltration for the separation of pharmaceuticals from nutrients in source-separated urine, ELSEVIER, Water Research, Vol. 40, pp 1405-1412.

Quintana, José Benito, Stefan Weiss and Thorsten Reemtsma (2005), Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor, ELSEVIER, Water Research, Vol. 39, pp 2654-2664.

Rempharmawater: http:/www.unina.it/~marotta

SST (2006a), Antal sengepladser ved offentlige sygehuse 2004-2005, Nye tal fra Sundhedsstyrelsen. Årgang 10, nr.16, http://www.im.dk/publikationer/foregangsland/index.htm

SST (2006b), Radiologiske ydelser ved offentlige sygehuse 2004-2005, Nye tal fra Sundhedsstyrelsen, Årgang 10, nr. 17, www.sst.dk.

Stockholms läns landsting (2004), Miljöklassificering av läkemedel – erfarenheter från Stockholm, http://www.lg.se/templates/Page.aspx?id=7323.

Tekin, Huseyin, Okan Bilkay, Selale S. Ataberk, Tolga H. Balta, I. Haluk Ceribasi, F. Dilek Sanin, Filiz B. Dilek and Ulku Yetis (2005), Use of Fenton oxidation to improve the biodegradability of a pharmaceutical wastewater, ELSEVIER, Journal of Hazardous Materials, B136, pp 258-265.

Ternes, T.A. (1998), Occurence of drugs in German sewage treatment plants and rivers, ELSEVIER Science, Water Research, Vol. 32, No. 11, pp 3245-3260.

Ternes, A. Thomas and Adriano Joss (2006), Human Pharmaceuticals, Hormones and Fragrances – The challenge of micropollutants in urban water management (2006), Published by IWA Publishing, UK. ISBN: 1843390930.

Vieno, N., T. Tuhkanen and L. Kronberg (2006), Removal of Pharmaceuticals in Drinking Water Treatment: Effect of Chemical Coagulation, Environmental Technology, Vol. 27, No. 2, pp 183-192.

von Gunten, Urs (2003), Ozonation of drinking water: Part I. Oxidation kinetics and product formation, ELSEVIER, Water Research, Vol. 37, pp 1443-1467.

Wricke, Burkhard (2006), Effizienz von Aufbereitungsverfahren zur Entfernung mikrobiologischer Belastungen, Wasser - Abwasser GWF 147, Nr. 13, pp S2-S6.

Yoon, Yeomin, Paul Westerhoff, Shane A. Snyder and Eric C. Wert (2006), Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products, ELSEVIER, Journal of Membrane Science, Vol. 270, pp 88-100.

 



Version 1.0 September 2007, © Miljøstyrelsen.